Article Details
Retrieved on: 2022-05-14 10:06:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... combination with various vector “delivery agents” (monoclonal antibodies (MAb) rituximab, tetulomab, cetuximab and huA33 and their fragments).
Article found on: indiaeducationdiary.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here